ChemoCentryx, Inc.
2-oxindole compounds
Last updated:
Abstract:
Oxindole compounds useful for the treatment of CCR(9) mediated conditions or diseases are provided.
Status:
Grant
Type:
Utility
Filling date:
17 Jul 2020
Issue date:
6 Sep 2022